Tags : Pre-Clinical

Pharma

Evotec Signs an Agreement with Celmatix to Develop Pre-Clinical Candidates

Shots: Evotec will take care of medicinal chemistry, in vitro and in vivo pharmacology plus its development capabilities and expertise while Celmatix will utilize its novel drug target discovery based on its multi-omics Reproductive Atlas platform The focus of the agreement is to combine Celmatix database and expertise with Evotec’s footprints in therapeutic discovery with […]Read More

Biotech

Lilly Acquires Hydra Biosciences with its Pre-Clinical Pain Program for

Shots: Lilly to acquire Hydra, in all stock transaction with its all pre-clinical pain program of TRPA1 antagonists The focus of the acquisition is to develop treatments for chronic pain and understand TRP pathway in pain signaling, further initiate clinical trials Hydra’s Transient Receptor Potential (TRP) channel program consists of group of non-selective cation channels indicated for the treatment […]Read More